Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2000
05/10/2000EP0998553A1 Protein tyrosine kinase 2(pyk2),nucleic acids, and assay
05/10/2000EP0998496A1 Isolated dendritic cell membrane protein genes
05/10/2000EP0998493A1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis
05/10/2000EP0998486A1 Protein recovery by chromatography followed by filtration upon a charged layer
05/10/2000EP0998305A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
05/10/2000EP0998302A1 Methods of delaying development of hmfg-associated tumors using anti-idiotype antibody 11d10
05/10/2000EP0998300A1 Methods and compositions for modulating responsiveness to corticosteroids
05/10/2000EP0840786A4 Gdu, a novel signalling protein
05/10/2000EP0649533B1 Reagents and methods for the detection and quantification of thyroxine in fluid samples
05/10/2000CN1252811A Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics
05/10/2000CN1252810A Antibody for inhibiting blood coagulation and method of use thereof
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252807A Neoglycoproteins
05/10/2000CN1252729A Production process for intravenous immune serum globulin and resultant product
05/10/2000CN1252448A Human actin related protein gene and encoded polypeptide and preparation and application
05/10/2000CN1252447A New human gene sequence and encoded polypeptide and the preparation
05/10/2000CN1252446A New human gene sequence and encoded polypeptide and the preparation and application
05/10/2000CN1252440A Avid kyowamycin regulation gene for improving disinsection mychel yield
05/10/2000CN1252408A Serial animal globulin foods and their production process
05/10/2000CA2287775A1 Attenuated forms of bovine viral diarrhea virus
05/09/2000US6060588 Bap-1 proteins
05/09/2000US6060587 Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
05/09/2000US6060303 Use in screening assays and as pharmaceuticals.
05/09/2000US6060296 Protein kinases
05/09/2000US6060295 Nucleic acids and expression systems encoding tyrosylprotein sulfo transferases
05/09/2000US6060294 Alanyl tRNA synthetase from Staphylococcus aureus
05/09/2000US6060285 Process for the production of hetero-bispecific antibodies
05/09/2000US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
05/09/2000US6060276 Nucleotide sequences for proteins involved in signal transduction; for assays to detect/measure ligands; diagnosis and therapy of endocrine disorders; gene therapy; antisense agents; transgenic animals
05/09/2000US6060272 Human G-protein coupled receptors
05/09/2000US6060259 Having molecular weight in presence of sodium dodecyl sulfate of between 44.5 and 47.5 kilodaltons; for detecting or monitoring the development of tuberculosis in man or cattle
05/09/2000US6060255 Having 7s domain in its structure and recovered from collagen solution by pepsin digestion and repeated salt precipitation; for sensitive diagnosis and progression of liver fibrosis
05/09/2000US6060253 Monoclonal antibody which specificially inhibits catalyzed metabolism of bufuralol; used to screen drugs for their metabolism by 2d6 and/or identify 2d6 poor metabolizers by simple bioassays
05/09/2000US6060250 Human transferases
05/09/2000US6060239 Cellubrevin homologs
05/09/2000US6060059 Haemophilus adhesion proteins
05/09/2000US6060056 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
05/09/2000US6060054 Product for T lymphocyte immunosuppression
05/09/2000US6060037 Conjugated compounds which comprise an st receptor binding moiety and a radiostable active moiety
05/09/2000CA2100586C Htlv-i and htlv-ii peptide antigens and methods
05/09/2000CA2058940C Targeted liposomes and methods for liposome-protein coupling
05/09/2000CA2057860C Immunoactive peptides and antibodies and their use in anti-allergy treatment
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024901A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024897A1 Cell surface molecule-induced macrophage activation
05/04/2000WO2000024896A2 Biological material for preparing pharmaceutical compositions for treating mammals
05/04/2000WO2000024890A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same
05/04/2000WO2000024889A1 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip
05/04/2000WO2000024888A1 CDNA SEQUENCE AND GENOMIC ORGANIZATION FOR A 59.4 KDA NEURONAL-SPECIFIC 7 TRANSMEMBRANE PROTEIN (pNEU60)
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024884A2 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility
05/04/2000WO2000024873A1 Process for recovering heterologous polypeptides from bacterial cells
05/04/2000WO2000024869A2 Methods for modulating cell fusion
05/04/2000WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents
05/04/2000WO2000024781A1 Conformation-specific anti-von willebrand factor antibodies
05/04/2000WO2000024780A2 Compositions and methods for treating polycystic kidney disease
05/04/2000WO2000024779A1 Lysine-rich statherin protein
05/04/2000WO2000024773A2 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000WO2000024771A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000WO2000024766A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000WO2000024765A2 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024758A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF
05/04/2000WO2000024751A1 Chelating agents for radioimmunotherapy
05/04/2000WO2000006743A3 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000002917A3 Compounds and methods for modulating cadherin-mediated functions
05/04/2000WO2000002897B1 Delta cleavage products and methods based thereon
05/04/2000WO1999067283A8 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof
05/04/2000WO1999064038A9 Novel analgesic agents
05/04/2000WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS
05/04/2000WO1999052944A8 G-protein coupled receptors
05/04/2000WO1999051781A9 Hepatitis c virus ns5b compositions and methods of use thereof
05/04/2000DE19856777A1 Anti-Petasin-Antikörper, Verfahren zu ihrer Herstellung und ihre Verwendung Anti-petasin antibodies, processes for their preparation and their use
05/04/2000DE19850680A1 Verfahren zur Bestimmung der Reparaturkapazität von DNS-Reparaturenzyme enthaltenden Lösungen und zum Nachweis von DNS-Strukturmodifikationen und Basenfehlpaarungen Method for determining the capacity of repair DNA repair enzymes containing solutions and for the detection of DNA-structure modifications and base mismatches
05/04/2000DE19849643A1 An das AAV-Kapsid bindender, den Zelltropismus verändernder Antikörper und Verfahren zum gerichteten Gentransfer At the AAV capsid binding, cell tropism changing antibodies and methods for directed gene transfer
05/04/2000CA2356595A1 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip
05/04/2000CA2349211A1 Prv-1 gene and the use thereof
05/04/2000CA2348989A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348839A1 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility
05/04/2000CA2348833A1 Human phospholipases
05/04/2000CA2348827A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348747A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348563A1 Compositions and methods for treating polycystic kidney disease
05/04/2000CA2348046A1 Lysine-rich statherin protein
05/04/2000CA2347983A1 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000CA2347294A1 Novel g protein coupled receptor protein, dna and its ligand
05/04/2000CA2347293A1 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000CA2347075A1 Cdna sequence and genomic organization for a 59.4 kda neuronal-specific 7 transmembrane protein (pneu60)
05/04/2000CA2347068A1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000CA2346976A1 Chelating agents for radioimmunotherapy
05/04/2000CA2344606A1 Conformation-specific anti-von willebrand factor antibodies
05/04/2000CA2344207A1 Biological material for preparing pharmaceutical compositions for treating mammals
05/03/2000EP0997529A2 Feline immunodeficiency virus strain FIV-141 and uses thereof
05/03/2000EP0997528A1 Streptomyces avermitilis regulatory genes for increased avermectin production
05/03/2000EP0997476A2 Antibodies to a mammalian Langerhans cell antigen and their uses
05/03/2000EP0997152A1 Remedies for lymphocytic tumors
05/03/2000EP0996857A2 Cancer associated nucleic acids and polypeptides
05/03/2000EP0996733A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human
05/03/2000EP0996730A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus
1 ... 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 ... 1494